Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02121041 · ClinicalTrials.gov registry record · NA

Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study

A NA study of Hypertension, sponsored by Anthony J Viera, MD, MPH.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT02121041: Completed NA study of Hypertension, sponsored by Anthony J Viera, MD, MPH.

NCT02121041 is a NA study of Hypertension that has completed, run by Anthony J Viera, MD, MPH. The registered enrollment target is 28 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02121041, a NA study of Hypertension, has completed, sponsored by Anthony J Viera, MD, MPH.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the effectiveness of ambulatory blood pressure monitoring to usual care (blood pressure measurement in the office) in diagnosing and managing hypertension.

Conditions Studied

Interventions

  • DRUG Losartan
  • DRUG Chlorthalidone
  • DRUG Amlodipine

Study Locations (1)

North Carolina

  • University of North Carolina - Chapel Hill

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2014-05
Est. Completion 2016-07
Phase NA
Anthony J Viera, MD, MPH

1 total trials

What the finished NCT02121041 record still lists

NCT02121041 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Losartan is the first listed.

NCT02121041 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02121041 about?

NCT02121041 is a clinical study titled "Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study". The purpose of this study is to compare the effectiveness of ambulatory blood pressure monitoring to usual care (blood pressure measurement in the office) in diagnosing and managing hypertension.

What is the current status of trial NCT02121041?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-05. Estimated completion is 2016-07.

What conditions does trial NCT02121041 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT02121041?

The interventions under investigation include: Losartan (DRUG), Chlorthalidone (DRUG), Amlodipine (DRUG).

Who is sponsoring clinical trial NCT02121041?

This trial is sponsored by Anthony J Viera, MD, MPH, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02121041 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02121041's enrollment target sits among peer trials

28 419th of 470 higher than 52 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02121041, the US trial registry maintained by the National Library of Medicine. NCT02121041 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.